Navigation Links
Interviews Of NW Bio's CEO, On The Floor Of The New York Stock Exchange, Now Available Online
Date:5/3/2013

BETHESDA, Md., May 3, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today the availability on the web of several interviews of their CEO Linda Powers on the floor of the New York Stock Exchange on May 1, 2013 by FOX Business News (FOX), the Huffington Post, and the International Business Times, amongst others.

(Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO)

In the FOX interview, Ms. Powers described the importance of NW Bio's DCVax technology in mobilizing a patient's whole immune system, and in targeting the full set of biomarkers on the cancer. This way, the DCVax treatment involves many active agents hitting many targets on the cancer, rather than just a single active agent hitting a single target, as is typical with cancer drugs and some other types of immune therapies. Ms. Powers explained that NW Bio's approach makes it harder for the tumor to "escape," which the Company believes is responsible for the striking results in clinical trials so far, adding years of survival in patients (rather than weeks or months) and doing so without toxicity. These results are clearly differentiating NW Bio from other players in this burgeoning field.

You can see the FOX interview at http://video.foxbusiness.com/v/2344168115001/latest-advances-in-cancer-research/

In the Huffington Post and New York Financial Press interview, Ms. Powers outlined in more detail the process for combining the tumor tissue biomarkers with the dendritic cells (master immune cells), obtained
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
2. Griffin Securities Analyst Interviews Unilife Corp. CEO in a Two-Part Video Series
3. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
4. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracleâ„¢ HER2 IHC System on the Leica BOND-MAX
5. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
6. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
7. BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility
8. Neurocrine Biosciences Reports First Quarter 2012 Results
9. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
10. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
11. BioSurplus Announces Launch of Depot Service for Agilent and AKTA HPLCs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 BreedIT Corp (OTC: ... worldwide distributor of highly sophisticated agro-breeding solutions for plant ... 2014, the Company,s board of directors appointed chemistry and ... its new member of the board. From ...
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... the risk of cancer returning,after surgery for ... April 12, 2007 /PRNewswire/ -- Investigators,will begin ... placebo in a major North American clinical ... Kit-positive,gastrointestinal stromal tumors treated with Gleevec following,surgery ...
... and NUTLEY, N.J., April 12, 2007,/PRNewswire-FirstCall/ -- ... trial program ever undertaken in the renal,anemia ... the,investigational anemia therapy MIRCERA(TM) for the treatment ... (CKD) in,patients on dialysis and not on ...
Cached Medicine Technology:Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 2Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 3Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 4Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 5Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 6Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 7Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 2Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 3Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 4
(Date:4/18/2014)... Benaroya Research Institute at Virginia Mason (BRI) recently ... molecule in metastatic breast cancer reduces both the growth ... BRI scientists have found in models of the disease ... - 80 percent and can keep the tumor from ... five-year grant comes from the National Cancer Institute of ...
(Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
(Date:4/17/2014)... chronic inflammation in non-cancerous prostate tissue may have nearly ... those with no inflammation, according to results of a ... Kimmel Cancer Center. , The link between persistent inflammation ... high-grade prostate cancer those with a Gleason score ... the most aggressive and rapidly growing prostate cancers. , ...
(Date:4/17/2014)... vaccine brands for children may not be the most ... factors when choosing vaccines, driving the market toward what ... new study by University of Illinois researchers. , "The ... numerous factors," says Sheldon H. Jacobson, a co-author of ... of mathematics at the U. of I. "In an ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2
... new studies show higher joint replacement complication rates, longer ... The prevalence of obesity is rising at ... with this life-altering condition may be putting their long-term ... at the 2009 Annual Meeting of the American ...
... Orthopaedic surgeon John J. Callaghan, MD was elected to ... Orthopaedic Surgeons ( http://www.aaos.org/ )(AAOS) at the organization,s 2009 ... Academy as First Vice-President.Having to wear a cast as a ... go into the field of orthopaedic surgery. "Breaking my ...
... that boys and girls can return to high-level sports ... high school athletes receiving anterior cruciate ligament ( ACL ... return to their sport at the same level, and ... rate. A new study presented today at the 2009 ...
... for psychiatric services following an emergency room visit are ... call for help, compared to about 20 percent of ... percent of all calls to mental health clinics in ... two weeks, according to a new University of Pennsylvania ...
... February 2009 Molecular Oncology (MOLONC) ... of the Federation of European Biochemical Societies (FEBS), ... for inclusion in the Science Citation Index Expanded ... , MOLONC (published 6 times a year from ...
... 8x BD writer drive, Vinpower Digital is able to offer the ... , ... Los Angeles, CA (PRWEB) February 25, 2009 ... Disc duplicator lines offering true 8X BD-R duplication speed. Using ...
Cached Medicine News:Health News:Obesity: A Musculoskeletal Nightmare 2Health News:Obesity: A Musculoskeletal Nightmare 3Health News:Obesity: A Musculoskeletal Nightmare 4Health News:John J. Callaghan, MD Elected Academy First Vice President 2Health News:John J. Callaghan, MD Elected Academy First Vice President 3Health News:Getting on the Ball, Post-ACL Surgery 2Health News:Getting on the Ball, Post-ACL Surgery 3Health News:For psychiatric services, wait for the beep 2Health News:For psychiatric services, wait for the beep 3Health News:Molecular Oncology accepted into Thomson Reuters index 2Health News:Vinpower Digital Increases Blu-ray Disc Duplication Speed to 8X for Both Their Manual Tower and Autoloader Series Duplicators 2Health News:Vinpower Digital Increases Blu-ray Disc Duplication Speed to 8X for Both Their Manual Tower and Autoloader Series Duplicators 3
Quantitative Plasma-based Factor XIII Incorporation Assay Kit...
Assay for Determination of Initial Thrombin Formation...
Thrombin Activatable Fibrinolysis Inhibitor Assay Kit...
Pefakit PiCT LMWH Calibrators...
Medicine Products: